GSK Stockmann at the IBA’s 14th London Finance and Capital Markets Conference

GSK Stockmann will be at the IBA’s 14th London Finance and Capital Markets Conference – presented by the IBA Taxes Committee.

The conference addresses current trends and critical issues in finance, tax policy, and capital markets, with a focus on structured financing, tax compliance, and international developments. Topics include:

• Half of the world voted in 2024: roundtable discussion
• Impact of avoidance rules on investment income
• Tax directors panel
• Pillar 2
• Securitisation transactions, what’s next after receivables and do taxes play a role
• Cross border finance – how to structure in view of increasingly complex rules
• Holding companies: state of play
• Cross-border corporate restructurings
• Spin offs and demergers: trends and traps
• Private equity and funds
• Navigating the stormy seas from an onslaught of transfer pricing audits and evolving transfer pricing rubrics
• Tax litigation
• Recent trends in M&A
• ABC: AI, big data and crypto
• Contested settlements and reliance on rulings + APA

Mathilde Ostertag (Partner at GSK Stockmann in Luxembourg) will be at the conference and speaking on a panel titled “Holding companies: state of play” – covering the following topics:

• Best jurisdictions (fact vs fiction): Ireland, Luxembourg, Netherlands, Spain, the United Arab Emirates (UAE) and the UK
• General anti-avoidance rules (GAARs) and specific anti-avoidance rules (SAARs) in the holding company context
• Substance requirements: update on Unshell and domestic substance requirements in the UAE and US
• US developments: treaty structures, status of the Trump tax reform and its impact on holding companies and the effect of Pillar 2

Further information about the conference and details how to register can be found here.